Sapiens International Corporation N.V. (SPNS)
USD 27.78
(-2.83%)
USD 27.78
(-2.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 514.58 Million | 474.73 Million | 461.03 Million | 382.9 Million | 325.67 Million | 289.7 Million |
| Cost of Revenue | 289.21 Million | 274.57 Million | 273.19 Million | 226.92 Million | 182.66 Million | 180.13 Million |
| Gross Profit | 225.36 Million | 200.16 Million | 187.84 Million | 155.97 Million | 143.01 Million | 109.56 Million |
| Operating Expenses | 141.29 Million | 133.67 Million | 130.35 Million | 110.97 Million | 90.8 Million | 86.54 Million |
| Selling, General and Administrative Expenses | 72.04 Million | 75.01 Million | 76.34 Million | 69.61 Million | 47.76 Million | 52.13 Million |
| Research and Development Expenses | 69.25 Million | 58.65 Million | 54.01 Million | 41.35 Million | 43.04 Million | 34.41 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 430.51 Million | 408.24 Million | 403.54 Million | 337.9 Million | 273.46 Million | 266.68 Million |
| Operating Income | 84.07 Million | 66.49 Million | 57.48 Million | 45 Million | 52.2 Million | 23.02 Million |
| Interest Expense | 340 Thousand | 1.42 Million | 3.79 Million | 3.8 Million | 3.03 Million | 3.22 Million |
| Income Tax Expense | 14.25 Million | 12.61 Million | 9.96 Million | 7.04 Million | 10.29 Million | 5.06 Million |
| Earnings before Tax | 77.11 Million | 65.55 Million | 57.28 Million | 41.19 Million | 49.43 Million | 19.06 Million |
| Net Income | 62.44 Million | 52.59 Million | 47.17 Million | 33.77 Million | 38.89 Million | 13.78 Million |
| Earnings Per Share Basic | 1.13 | 0.95 | 0.86 | 0.66 | 0.52 | 0.28 |
| Earnings Per Share Diluted | 1.12 | 0.95 | 0.85 | 0.65 | 0.52 | 0.28 |
| Weighted Average Shares Outstanding | 55.37 Million | 55.11 Million | 54.78 Million | 51.2 Million | 50.03 Million | 49.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.72 Million | 55.57 Million | 55.59 Million | 52.15 Million | 50.65 Million | 50.1 Million |
| Gross Margin | 0.44 | 0.42 | 0.41 | 0.41 | 0.44 | 0.38 |
| EBIT Margin | 0.18 | 0.19 | 0.19 | 0.18 | 0.22 | 0.15 |
| Profit Margin | 0.12 | 0.11 | 0.10 | 0.09 | 0.12 | 0.05 |
| EBITDA | 94.85 Million | 83.52 Million | 84.11 Million | 63.62 Million | 51.33 Million | 42.88 Million |
| Earnings Before Tax Margin | 0.16 | 0.14 | 0.12 | 0.12 | 0.16 | 0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 136.8 Million | 134.24 Million | 514.58 Million | 130.85 Million | 130.7 Million | 128.29 Million |
| Cost of Revenue | 75.12 Million | 75.14 Million | 289.21 Million | 74.91 Million | 74.75 Million | 73.63 Million |
| Gross Profit | 61.67 Million | 59.1 Million | 225.36 Million | 55.94 Million | 55.95 Million | 54.66 Million |
| Operating Expenses | 39.42 Million | 38.58 Million | 141.29 Million | 35.86 Million | 35.68 Million | 35.04 Million |
| Selling, General and Administrative Expenses | 21.04 Million | 20.51 Million | - | 19.77 Million | 19.65 Million | 19.29 Million |
| Research and Development Expenses | 18.37 Million | 18.06 Million | - | 16.08 Million | 16.02 Million | 15.74 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 114.55 Million | 113.72 Million | 430.51 Million | 110.77 Million | 110.44 Million | 108.67 Million |
| Operating Income | 22.24 Million | 20.52 Million | 84.07 Million | 20.08 Million | 20.26 Million | 19.62 Million |
| Interest Expense | - | - | 1.75 Million | - | 551 Thousand | 562 Thousand |
| Income Tax Expense | 4.37 Million | 4.11 Million | 14.25 Million | 3.62 Million | 3.71 Million | 3.58 Million |
| Earnings before Tax | 22.99 Million | 21.61 Million | 77.11 Million | 20.64 Million | 19.71 Million | 19.05 Million |
| Net Income | 18.61 Million | 17.36 Million | 62.44 Million | 16.97 Million | 15.87 Million | 15.4 Million |
| Earnings Per Share Basic | 0.33 | 0.31 | - | 0.30 | 0.29 | 0.28 |
| Earnings Per Share Diluted | 0.33 | 0.31 | - | 0.30 | 0.28 | 0.28 |
| Weighted Average Shares Outstanding | 55.79 Million | 55.74 Million | 55.37 Million | 55.73 Million | 55.39 Million | 55.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.16 Million | 55.98 Million | 55.72 Million | 55.91 Million | 55.81 Million | 55.58 Million |
| Gross Margin | 0.45 | 0.44 | 0.44 | 0.43 | 0.43 | 0.43 |
| EBIT Margin | 0.19 | 0.18 | - | 0.20 | 0.19 | 0.19 |
| Profit Margin | 0.14 | 0.13 | 0.12 | 0.13 | 0.12 | 0.12 |
| EBITDA | 25.37 Million | 24.63 Million | - | 25.73 Million | 25.31 Million | 24.95 Million |
| Earnings Before Tax Margin | 0.16 | 0.15 | 0.16 | 0.15 | 0.16 | 0.15 |
BIOCQ
ASND
002199
HTCMF
AYA
NER